IV. 13. Seafood Consumption

From the right source, seafood offers one of the most complete animal proteins; its omega-3s, zinc, and selenium strengthen the gut barrier and a stable microbiota.

Seafood – Nutrient-Dense Protein That Supports Gut and Metabolic Health

When sourced responsibly, seafood is one of the most complete and gut-friendly animal proteins.

In the decade after Bang and Dyerberg published their Greenland Inuit data, the question of whether eating fish could actually prevent cardiovascular deaths remained unanswered. Observational associations are not causation. What was needed was a randomised trial. In 1989, Michael Burr and colleagues at the Medical Research Council Epidemiology Unit in Cardiff published the Diet and Reinfarction Trial – DART – in the Lancet. The trial enrolled two thousand men who had recently survived a myocardial infarction. Participants were randomised to receive dietary advice about fat reduction, fish consumption, or increased fiber intake, in a factorial design. The fish advice group was told simply to eat at least two portions of fatty fish per week, or to take fish oil capsules if they could not tolerate that amount. [142] The results after two years were striking. Men who received advice to eat fatty fish had a 29% reduction in total two-year mortality compared with those who did not receive fish advice. The reduction was concentrated in coronary deaths. The fat-reduction and fiber-increase arms showed no significant mortality benefit over the same period. DART was not a perfect trial – compliance was imperfect, and the fish advice group also changed other aspects of their eating – but it was the first randomised evidence that fish consumption, specifically its omega-3 fatty acid content, could influence clinical survival outcomes. [120] What DART could not show was the mechanism. In 1989, the gut microbiota had not yet been established as a relevant variable. We now understand that the omega-3 fatty acids in oily fish reduce intestinal inflammation and bile-acid-driven microbial dysbiosis; that the zinc, selenium, and vitamin D in seafood support mucosal barrier integrity; and that intact barriers allow stable microbial communities. The fish Burr's trial participants were eating was not a pharmaceutical intervention. It was food whose systemic effects happened to include a more stable gut environment – which, in people already compromised by myocardial injury and likely by metabolic dysbiosis, may have contributed more than was then understood.

Seafood provides a concentrated source of high-quality protein, long-chain omega-3 fatty acids, iodine, selenium, zinc, and vitamin D. These nutrients support immune regulation, metabolic stability, and tissue repair. Because immune activity, bile-acid metabolism, and inflammation influence the intestinal environment, adequate seafood intake can indirectly affect the gut microbiota [120][122].

Fatty fish such as salmon, sardines, herring, and mackerel supply EPA and DHA. These omega-3 fatty acids reduce inflammatory signaling and modify bile-acid composition, which may influence microbial activity in the intestine. Human studies suggest that omega-3 intake can modestly alter microbiota composition, although the effects vary and depend on the overall diet [122].

Shellfish contribute trace minerals needed for enzymes involved in immune function and antioxidant defense. Adequate micronutrient status supports mucosal barrier integrity and recovery from inflammation. This effect is indirect but important for maintaining a stable microbial ecosystem [143].

Seafood also supplies vitamin D and long-chain omega-3 fats that are difficult to obtain from plant foods alone. Adequate intake is associated with improved metabolic health and lower chronic inflammation. These systemic effects help create a favorable environment for microbial balance.

At the same time, seafood quality matters. Large predatory fish may accumulate mercury or persistent pollutants. Choosing smaller fish and seafood from regulated fisheries helps reduce exposure while preserving nutritional benefit.

Moderate intake is recommended in most clinical guidelines, usually one to three seafood meals per week. This level provides omega-3 fatty acids and trace minerals while allowing room in the diet for vegetables, legumes, and whole grains, which remain the main drivers of microbiota diversity.

Cooking methods also influence nutritional value. Steaming, baking, or grilling preserves nutrients better than deep-frying, which adds oxidized fats and excess calories.

In summary, seafood is a valuable component of a balanced diet. Its main contribution to gut health is indirect—through improved nutrient status and reduced inflammation—while dietary fiber from plant foods remains the primary determinant of microbiota diversity.

Clinical Considerations for Seafood Intake and Gut Health

Regular inclusion of seafood, particularly oily fish, can help maintain adequate intake of long-chain omega-3 fatty acids, while smaller species tend to provide similar nutrients with lower contaminant exposure.

A varied seafood pattern contributes a broader micronutrient profile, as fatty fish, lean white fish, and shellfish differ in their content of iodine, selenium, zinc, vitamin D, and protein.

Preparation methods influence nutritional value. Gentle cooking techniques such as baking, steaming, or grilling preserve omega-3 fatty acids better than deep-frying or heavily processed seafood products.

Seafood should be considered within the context of responsible sourcing, since regulated fisheries or certified aquaculture systems generally reduce exposure to environmental contaminants and antibiotic residues.

Meals that combine seafood with vegetables, legumes, and whole grains support overall gut health, because seafood provides essential nutrients while plant foods supply the fermentable fibers that drive microbial diversity.

Microbiota Effects

• Omega-3 fatty acids from seafood may modestly influence gut microbiota composition, mainly through reduced intestinal inflammation and altered bile-acid metabolism rather than by directly increasing specific bacterial species. Reported changes vary between individuals and study designs [122].
• Omega-3 intake has been associated in some studies with higher abundance of certain short-chain-fatty-acid–producing taxa, such as Faecalibacterium prausnitzii or Roseburia spp., although consistent increases in Lactobacillus or Bifidobacterium have not been clearly demonstrated in humans [122].
• Seafood-derived micronutrients (zinc, selenium, iodine, vitamin D) support mucosal immune function and epithelial repair. Improved barrier integrity can indirectly stabilize microbial ecosystems by reducing inflammatory signaling and intestinal permeability [144].
• Omega-3 fatty acids influence host metabolism and neural signaling, which may affect the gut–brain axis through pathways involving bile acids, cytokines, and microbial metabolites. These effects are indirect and depend on overall diet and health status.
• Seafood consumption alone does not drive microbial diversity. Microbiota richness depends primarily on dietary fiber from plant foods. Pairing seafood meals with vegetables, legumes, and whole grains provides fermentable substrates that support SCFA production [85].
• Non-bacterial microbiota components may also respond to dietary fat composition, including shifts in methanogenic archaea (e.g., Methanobrevibacter smithii), fungal taxa such as Candida or Saccharomyces, and bacteriophage populations, although evidence is limited.
• Contaminants in seafood can influence microbiota indirectly, as exposure to heavy metals or persistent pollutants has been associated with altered microbial composition in observational studies [143].
• Overall, seafood affects the microbiota mainly through systemic pathways—reduced inflammation, improved nutrient status, and bile-acid signaling—rather than acting as a primary prebiotic or probiotic food.

Patient Guidance

• Eat seafood 1–3 times per week, including at least one portion of oily fish (sardines, mackerel, salmon).
• Add shellfish occasionally (mussels, clams, oysters) if tolerated, for zinc and selenium intake.
• Prefer smaller fish to reduce mercury exposure.
• Choose trusted, regulated sources of seafood whenever possible.
• Avoid fried or heavily processed seafood; use baking, steaming, or grilling instead.
• Always combine seafood with vegetables, legumes, or whole grains to support microbiota through fiber intake.
• Limit large predatory fish (e.g., tuna, swordfish) to occasional meals.
• Rotate seafood types to diversify nutrient intake.
• Notice how your body responds - energy level, digestion, stool pattern, or allergy symptoms.
• Discuss seafood intake with your doctor if you are pregnant, have thyroid disease, or follow a restricted diet.

References

[85] Holscher, H. D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017. Link

Review of dietary strategies — fibre and prebiotic consumption — to modulate the gastrointestinal microbiota and its metabolic function for health benefit. Most complex carbohydrates and plant polysaccharides are not digested by human enzymes but are fermented by gut microbes into SCFAs and other bioactive metabolites. The review summarizes mechanisms and clinical applications and frames prebiotic intake as a primary lever for microbiome-targeted disease prevention and treatment.

[120] Calder, P. C. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017. Link

Review of omega-6 and omega-3 fatty acid roles in inflammation. EPA and DHA from oily fish or fish-oil supplements partly inhibit leucocyte chemotaxis, adhesion molecule expression, leucocyte-endothelial interactions, and the production of arachidonic-acid-derived eicosanoids and pro-inflammatory cytokines. EPA-derived eicosanoids are typically less potent than those from arachidonic acid, and EPA/DHA give rise to anti-inflammatory and inflammation-resolving mediators (resolvins, protectins, maresins), supporting their use in inflammatory conditions.

[122] Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci. 2017. Link

Long-term dietary habits shape host-specific gut microbiota, but dietary fat effects are less well characterised than those of carbohydrates. The few adult human omega-3 PUFA supplementation studies show consistent changes: decreased Faecalibacterium, increased Bacteroidetes and butyrate-producing Lachnospiraceae. Because dysbiosis of these taxa occurs in inflammatory bowel disease, omega-3 PUFAs may exert a beneficial effect by restoring microbial composition and increasing anti-inflammatory short-chain fatty acid production.

[142] Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989. Link

Burr and colleagues' DART (Diet and Reinfarction Trial, Lancet 1989) is a landmark randomised trial of dietary interventions after myocardial infarction in 2033 British men. Participants received advice to alter intake of fat, fatty fish, or cereal fiber in a 2×2×2 factorial design. After two years, the fish-advice group showed a 29% reduction in all-cause mortality compared to no-fish advice, while changes in fat or fiber alone did not significantly affect mortality. The trial provided early secondary-prevention evidence for fatty fish (omega-3) intake post-MI and shaped subsequent cardiology dietary guidance. Later DART-2 in angina patients found more equivocal results.

[143] Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012. Link

Review of mechanisms by which the gut microbiota influences host metabolism, with implications for obesity, cardiovascular disease and metabolic syndromes including type 2 diabetes. The microbiota modulates host metabolic pathways by improving energy yield from food and by altering dietary and host-derived compound bioactivity. Better mechanistic understanding will support the development of metabolic-disease treatments targeting the microbiota.

[144] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link

Cani and colleagues' 2007 Diabetes paper introduced the concept of 'metabolic endotoxemia' as a microbiota-driven trigger of obesity and insulin resistance. In mice, they show that a high-fat diet increases intestinal permeability and circulating lipopolysaccharide (LPS) levels, which activate TLR4-CD14 signalling and induce low-grade inflammation in adipose tissue, liver and muscle. Chronic subcutaneous LPS infusion in mice was sufficient to reproduce diet-induced obesity, insulin resistance and hepatic steatosis. CD14-knockout mice were protected. The paper established a mechanistic axis linking gut microbiota, barrier function and metabolic disease that has shaped subsequent obesity-microbiome research.